glp 1 agonist meds America's Poison Centers GLP-1 Receptor Agonists | New

One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick

"Once-Weekly Semaglutide in Adults with Overweight or Obesity." NEJM

It takes several weeks for the medication to build up to its full concentration in your bloodstream

What Are GLP-1 Medications

However, GLP-1 receptor agonists have shown the most promise of all the classes of medications

Semaglutide (marketed as 'Ozempic' and 'Wegovy') and the dual-agonist Tirzepatide ('Mounjaro' and 'Zepbound') are some of today's most talked-about medications, given their unprecedented clinical efficacies across both weight loss and T2D management